Mettler-Toledo International Inc. (NYSE:MTD) Receives Average Recommendation of “Hold” from Brokerages

Mettler-Toledo International Inc. (NYSE:MTD) has been given a consensus recommendation of “Hold” by the nine analysts that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $1,351.25.

Several brokerages recently weighed in on MTD. Stifel Nicolaus cut their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Wolfe Research started coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. Robert W. Baird decreased their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday, November 11th. Finally, Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their target price for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th.

Insider Activity at Mettler-Toledo International

In related news, insider Gerry Keller sold 140 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at $7,524.54. This represents a 95.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now directly owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

Hedge funds have recently modified their holdings of the business. JPMorgan Chase & Co. grew its stake in shares of Mettler-Toledo International by 14.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after purchasing an additional 28,478 shares during the last quarter. Quest Partners LLC grew its stake in shares of Mettler-Toledo International by 878.1% during the 3rd quarter. Quest Partners LLC now owns 1,027 shares of the medical instruments supplier’s stock worth $1,540,000 after purchasing an additional 922 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in shares of Mettler-Toledo International by 14.0% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock valued at $1,860,000 after purchasing an additional 152 shares during the period. M&T Bank Corp boosted its holdings in Mettler-Toledo International by 14.3% during the third quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock worth $7,387,000 after buying an additional 615 shares in the last quarter. Finally, Federated Hermes Inc. grew its position in Mettler-Toledo International by 10.3% during the second quarter. Federated Hermes Inc. now owns 7,667 shares of the medical instruments supplier’s stock worth $10,715,000 after buying an additional 717 shares during the period. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,325.38 on Wednesday. The company’s 50 day simple moving average is $1,242.44 and its 200-day simple moving average is $1,343.58. Mettler-Toledo International has a 1 year low of $1,133.46 and a 1 year high of $1,546.93. The company has a market capitalization of $27.97 billion, a price-to-earnings ratio of 35.73, a price-to-earnings-growth ratio of 4.10 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The company had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. Equities analysts expect that Mettler-Toledo International will post 40.42 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.